Cerebroprotein Hydrolysate calculator
A brain-derived peptide mixture similar to Cerebrolysin, used in some countries for neurological conditions. Not approved in the US.
Also known as: Cerebroprotein, Brain protein hydrolysate
FDA status — not an approved drug Not FDA-approved in the United States. Cerebroprotein hydrolysate is used in some other countries but is not FDA-approved, and its evidence base is limited and contested.
This draw does not fit the selected syringe.500 units exceeds the 100-unit barrel. Choose a larger syringe, use less bacteriostatic water, or split the dose.
Schedule Cerebroprotein Hydrolysate → Set your dosing schedule and get a phone notification when each dose is due. Free.
What Cerebroprotein Hydrolysate is
Cerebroprotein hydrolysate is a mixture of small peptides derived from brain tissue, similar to Cerebrolysin, used in some countries for stroke, dementia, and other neurological conditions. It is not FDA-approved in the United States, and its evidence base is limited and contested.
Research depth: 1/5 Limited, contested regional trial record; not FDA-approved. Human trials: Regional studies only. This measures how much has been studied — counting animal and laboratory work — not whether it works for you.
How Cerebroprotein Hydrolysate works
It is proposed to supply neurotrophic-like peptides that support neuronal survival and repair. As a complex biological mixture rather than a single defined molecule, its pharmacology is difficult to characterize precisely, which limits rigorous evaluation.
Cerebroprotein Hydrolysate side effects
Commonly reported
- Injection-site or infusion reactions
- Headache
- Nausea
Serious — seek medical care
- Evidence base is limited and contested
- A complex biological mixture with batch variability
- Not FDA-approved; products in the US are unregulated
This list is not exhaustive. Report anything unexpected to the clinician who prescribed it. If you have severe abdominal pain, trouble breathing, or signs of an allergic reaction, seek care the same day. See also our guide to peptide side effects by class.
A worked example
A 30 mg vial reconstituted with 5 mL of bacteriostatic water gives 6 mg/mL. A 30000 mcg dose is then 5 mL — about 500 units on a 100-unit insulin syringe, giving roughly 1 doses per vial before accounting for residual volume left in the vial and syringe.
Prefer paper? Download the printable Cerebroprotein Hydrolysate dosing chart (PDF) — every vial size and water volume in syringe units, with the same review byline as this page. All charts →
Commonly cited dose range
Figures circulating for Cerebroprotein Hydrolysate run from 10000 mcg to 60000 mcg. Dosing in countries where it is used is by milliliters of the preparation, given by injection or IV. Figures shown are total milligrams in micrograms. It is administered clinically, not as a home reconstitution.
Read this as reference information, not instruction. These numbers describe what is commonly discussed, not what is right for any individual. Dose, frequency, and whether to use Cerebroprotein Hydrolysate at all are decisions for a licensed clinician who knows your history.
Common questions
Is cerebroprotein hydrolysate approved in the US?
No. Like Cerebrolysin, it is a brain-derived peptide mixture used in some other countries but not approved by the FDA, and its evidence base is limited.
How is it different from Cerebrolysin?
They are similar brain-derived peptide hydrolysates from different manufacturers. Both are complex mixtures rather than single defined molecules, and both have contested evidence.